Medicare Enrolled
Dr. Apoorva Chawla, M.D.
Hematology & Oncology · Findlay, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chawla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chawla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chawla
Dr. Apoorva Chawla is a hematology & oncology specialist in Findlay, OH, with 17 years of NPI registration. Based on federal Medicare data, Dr. Chawla performed 1,367 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Chawla received a total of $5,909 from 62 pharmaceutical and/or device companies across 293 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chawla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 25% volume in OH
$5,909 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,367
Medicare services
Top 25% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
378 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
330 | $80 | $224 |
| Anti-nausea injection (Aloxi/palonosetron) | 210 | $1 | $7 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
124 | $124 | $303 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
76 | $21 | $58 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
56 | $95 | $253 |
| New patient office visit, complex (60-74 min) | 39 | $150 | $402 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $108 | $319 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
32 | $1 | $3 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
29 | $11 | $42 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
25 | $10 | $48 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
15 | $47 | $130 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
15 | $90 | $208 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
10.8% high complexity
49.3% medium
39.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,909
Total received (2018-2024)
Avg $844/year across 7 years
Top 35% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
293
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,214
2023
$748
2022
$907
2021
$66
2020
$226
2019
$1,375
2018
$1,373
Payments by company (2024)
E.R. Squibb & Sons, L.L.C.
$263
PFIZER INC.
$93
Daiichi Sankyo Inc.
$92
AstraZeneca Pharmaceuticals LP
$86
Merck Sharp & Dohme LLC
$63
GlaxoSmithKline, LLC.
$57
Celgene Corporation
$54
Incyte Corporation
$53
Janssen Biotech, Inc.
$52
Adaptive Biotechnologies Corporation
$49
Genentech USA, Inc.
$44
Astellas Pharma US Inc
$42
Novartis Pharmaceuticals Corporation
$35
Lilly USA, LLC
$34
Blueprint Medicines Corporation
$28
ABBVIE INC.
$25
Gilead Sciences, Inc.
$23
TAIHO ONCOLOGY, INC.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Pharmacosmos Therapeutics Inc.
$18
Eisai Inc.
$17
Rigel Pharmaceuticals, Inc.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$16
Kite Pharma, Inc.
$14
Top 3 companies account for 36.9% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$533
E.R. Squibb & Sons, L.L.C.
$516
PFIZER INC.
$367
Amgen Inc.
$327
Novartis Pharmaceuticals Corporation
$320
AstraZeneca Pharmaceuticals LP
$295
Janssen Biotech, Inc.
$294
Seattle Genetics, Inc.
$178
Seagen Inc.
$178
Merck Sharp & Dohme Corporation
$171
Incyte Corporation
$161
Celgene Corporation
$150
Takeda Pharmaceuticals U.S.A., Inc.
$147
Daiichi Sankyo Inc.
$146
Pharmacyclics LLC, An AbbVie Company
$139
Merck Sharp & Dohme LLC
$136
Lilly USA, LLC
$126
Janssen Scientific Affairs, LLC
$125
SANOFI-AVENTIS U.S. LLC
$99
Adaptive Biotechnologies Corporation
$90
GENZYME CORPORATION
$90
MorphoSys, US Inc.
$72
Bayer HealthCare Pharmaceuticals Inc.
$62
Astellas Pharma US Inc
$60
Rigel Pharmaceuticals, Inc.
$57
GlaxoSmithKline, LLC.
$57
Gilead Sciences, Inc.
$53
Pharmacyclics LLC, an AbbVie Company
$53
Helsinn Therapeutics (U.S.), Inc.
$52
EISAI INC.
$48
Karyopharm Therapeutics Inc.
$47
Regeneron Healthcare Solutions, Inc.
$46
Dendreon Pharmaceuticals LLC
$43
Eisai Inc.
$40
Kyowa Kirin, Inc.
$38
Exelixis Inc.
$37
EMD Serono, Inc.
$34
JAZZ PHARMACEUTICALS INC.
$33
Verastem, Inc.
$31
Alnylam Pharmaceuticals Inc.
$30
Blueprint Medicines Corporation
$28
ABBVIE INC.
$25
PUMA BIOTECHNOLOGY, INC.
$24
ARRAY BIOPHARMA INC
$23
Otsuka America Pharmaceutical, Inc.
$23
MACROGENICS, INC.
$22
Janssen Pharmaceuticals, Inc
$22
TerSera Therapeutics LLC
$22
Ipsen Biopharmaceuticals, Inc
$21
TAIHO ONCOLOGY, INC.
$21
Alexion Pharmaceuticals, Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
Blue Earth Diagnostics Limited
$19
Pharmacosmos Therapeutics Inc.
$18
Mirati Therapeutics, Inc.
$17
Puma Biotechnology, Inc.
$16
Taiho Oncology, Inc.
$16
Fortovia Therapeutics, Inc.
$15
BeiGene USA, Inc.
$15
Kite Pharma, Inc.
$14
TOLMAR Pharmaceuticals, Inc.
$14
AMAG Pharmaceuticals, Inc.
$11
Top 3 companies account for 24.0% of all-time payments
Associated products mentioned in payments ›
6 · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · Axumin · BEVESPI AEROSPHERE · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELIGARD · ELIQUIS · ELITEK · EMEND · ENHERTU · ERLEADA · Enhertu · Erleada · FERAHEME · GAZYVA · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONUREG · OPDIVO · OPDUALAG · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · SCEMBLIX · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TRUSELTIQ · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · XALKORI · XARELTO · XPOVIO · Xermelo · Xtandi · Yescarta · ZEPZELCA · ZYKADIA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
6
County median income
$69,699
Nearest hospital to ZIP centroid (approximate)
BLANCHARD VALLEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chawla is a clinical cardiology specialist, with above-average Medicare volume (top 25% in OH), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chawla experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Chawla performed 378 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chawla receive payments from pharmaceutical companies?
Yes. Dr. Chawla received a total of $5,909 from 62 companies across 293 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chawla's costs compare to other hematology & oncology specialists in Findlay?
Dr. Chawla's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chawla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Findlay
Browse hematology & oncology specialists in Findlay ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology